Viewing Study NCT02822651


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-02 @ 5:52 PM
Study NCT ID: NCT02822651
Status: COMPLETED
Last Update Posted: 2025-12-19
First Post: 2016-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Hypovitaminosis D Prediction Score
Sponsor: Hospices Civils de Lyon
Organization:

Study Overview

Official Title: SCOPYD Study: Development of a Predictive Clinical Score of Hypovitaminosis D
Status: COMPLETED
Status Verified Date: 2025-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCOPYD
Brief Summary: Vitamin D has effects on many tissues, and hypovitaminosis D is frequent. In a French survey conducted among 1587 adults, vitamin D insufficiency (\<30ng/ml) has been reported in 80% of subjects, including 43% with moderate deficiency (\<20ng/ml) and 5% with severe deficiency (\<10ng/ml).

Because of the possible consequences of hypovitaminosis D (osteomalacia in adults…), the number of vitamin D determination has increased ten-fold since 2005 in France, reaching 4.5 million € in 2011, and with it the costs for health insurance. However, there is currently no consensus on the strategy for detection, diagnosis and treatment of hypovitaminosis D.

We propose to develop a predictive clinical score of hypovitaminosis D based on the accurate assessment of solar exposure, vitamin D intakes and hypovitaminosis D risk factors collected through a self-administered questionnaire.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: